NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Daily Tech Geek

Volkswagen says it will pay Indian fine even as it appeals

Jan 19, 2019

NEW DELHI — Volkswagen Group said Friday that it will pay a fine of 1 billion rupees ($14.2 million) imposed by India for installing software on vehicles that allegedly cheated pollution testing devices, though it is still appealing the order. The company said it has challenged the National Green Tribunal's order in India's top court. Company spokesman Gagan Mangal declined to say Friday whether the company had transferred the money to India's Central Pollution Control Board. The panel set Friday as the deadline for payment. The company said in a statement that all Volkswagen cars were compliant with emission regulations...

Iran satellite fails to reach orbit in US-criticized launch

Jan 19, 2019

TEHRAN, Iran — An Iranian satellite-carrying rocket blasted off into space Tuesday, but scientists failed to put the device into orbit in a launch criticized by the United States as helping the Islamic Republic further develop its ballistic missile program. After the launch, Secretary of State Mike Pompeo repeated his allegation that Iran's space program could help it develop a missile capable of carrying a nuclear weapon to the mainland U.S., criticism that comes amid the Trump administration's maximalist approach against Tehran after withdrawing from the nuclear deal. Iran, which long has said it does not seek nuclear weapons, maintains...

The Latest: US criticizes Iran's attempted satellite launch

Jan 19, 2019

TEHRAN, Iran — The latest on Iran's failed satellite launch into orbit on Tuesday (all times local): 1:55 a.m. The U.S. State Department is condemning Iran's failed satellite launch as an action that defies the international community. Secretary of State Mike Pompeo said in a statement Tuesday that the vehicle which Iran attempted to launch into orbit uses technology "virtually identical and interchangeable with those used in ballistic missiles, including intercontinental ballistic missiles." Pompeo added that that the launch "furthers Iran's ability to eventually build such a weapon." He said the U.S. is working with its partners "to counter the...

India's mega Hindu festival begins under cloud of toxic air

Jan 19, 2019

PRAYAGRAJ, India — Thousands of portable toilets line roads constantly swept clean, drinking water flows from newly installed taps, electric substations power a massive tent city and billboards encourage a "clean Kumbh," an extension of Indian Prime Minister Narendra Modi's huge push to improve sanitation across the country. But the skies over the confluence of sacred rivers in northern India where millions of Hindu priests and pilgrims have come to wash away their sins at the ancient Kumbh Mela festival are thick with toxic dust, a sign that government officials are struggling to grapple with the country's worsening air pollution....

Iran says it will send 2 satellites to orbit amid US concern

Jan 19, 2019

TEHRAN, Iran — Iran's president said Thursday the Islamic Republic soon will send two new satellites into orbit using Iran-made rockets, despite U.S. concern the launch could help further develop its ballistic missiles. President Hassan Rouhani's comments, during a commemoration for the late President Akbar Hashemi Rafsanjani, confirmed the rocket launches would take place. Iran typically displays achievements in its space program in February, during the anniversary of the 1979 Islamic Revolution. This year will mark the 40th anniversary of the revolution, which saw the Persian monarchy of Shah Mohammad Reza Pahlavi replaced by the Islamic Republic overseen by a...

About Us

Daily Tech Geek delivers Technology news only covering the multiple fields in the industry.

Contact us: sales[at]dailytechgeek.com

Subscribe Now!